According to the recent research report titled ‘Global bovine mastitis market size study by Type (Clinical and Sub-Clinical), Product (Antibiotics, Surgery, Vaccines, Pain Killers, and Others), Route of Administration (Intra-Mammary and Systemic), By Therapy (Lactating Period and Dry Period), End Users (Hospitals, Veterinary Centers, and Others), Regional Forecasts 2021-2027’, available with MarketStudyReport, global bovine mastitis market size is expected to a expand with a CAGR of 5.1% over 2021-2027.
 

As per the findings of the research literature, global bovine mastitis market growth is mainly driven by rising incidences of the ailment and increasing product launches for animal healthcare.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/4219637/
 

Increasing R&D by pharma for new products will continue to expand the business horizon in the forthcoming years. Citing an instance, in October 2018, Boehringer Ingelheim International GmbH, unveiled a new medicine to protect dairy cattle from immunological diseases.
 

'Lockout,' a treatment developed by the business, assists dairy cattle in avoiding post-immunotherapy issues while also improving their health and performance. This will also enhance the quality of the dairy farm's final goods.
 

For the uninitiated, bovine mastitis is a disorder that causes inflammation of the mammary gland and udder tissue in dairy animals. One of the main reasons why the disease is regarded as a serious issue is that it can impair the cattle's milk-secreting tissues. Mastitis is also a threat to human health as it can lead to zoonoses and food toxin diseases.
 

Coming to challenges plaguing worldwide bovine mastitis industry, lack of awareness about the disease is likely to pose a threat to the revenue flow over 2021-2027.
 

Coming to regional landscape, North America (U.S., Canada), Europe (U.K., Germany, Spain, France, Italy), Asia Pacific (India, China, Australia, Japan, South Korea), and Latin America (Brazil, Mexico) are the key areas highlighted in the research literature.
 

Experts cite that North America presently accounts for considerable industry share and is predicted to depict a similar trend in the coming years, creditable to strong presence of large-scale companies, and growing acceptance of intra-mammary products for the treatment.
 

Prominent firms impacting global bovine mastitis market trends are DeLaval Inc., Norbrook Laboratories Ltd., Bayer AG, Nimrod Veterinary Products Ltd., Merck & Co. Inc., ImmuCell Corporation (ICCC), Westway Health, Boehringer Ingelheim International GmbH, Zoetis Inc., and Advanced Animal Diagnostics.